Sepracor launches Omnaris Nasal Spray in US
Omnaris Nasal Spray is indicated for the treatment of nasal symptoms associated with seasonal allergic rhinitis in adults and children six years of age and older, and with
BeOne Medicines is set to invest $300m in expanding its manufacturing and research operations at the Princeton West Innovation Campus in Hopewell, New Jersey, US.